Berentzen-Gruppe (BEZ) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
14 Aug, 2025Executive summary
First half of 2025 saw challenging market conditions, especially in Germany, with declining consumer sentiment and significant revenue drops in the spirits market.
Marketing investments in core brands led to market share gains in food retail, but discount retail underperformed, impacting overall brand development.
Mio Mio brand achieved 13.2% revenue growth year-over-year, offsetting some negative impacts from the sale of the Grüneberg site in non-alcoholic beverages.
Strong performance in higher-value private label spirits, with over 10% revenue growth compared to the prior year.
Consolidated profit improved to EUR 0.6 million from a loss of EUR -2.9 million year-over-year, mainly due to lower interest expenses and absence of exceptional effects.
Financial highlights
Consolidated revenues (excl. alcohol tax) fell 9.6% year-over-year to EUR 79.9 million.
EBITDA declined 21.0% to EUR 7.4 million; EBIT dropped 37.5% to EUR 3.2 million.
Contribution margin after marketing budgets decreased 15.2% to EUR 29.2 million.
Operating cash flow was EUR 6.4 million, down 14.1% year-over-year.
Equity ratio increased to 36.4% from 33.1% year-over-year.
Outlook and guidance
2025 full-year guidance revised: revenues expected between EUR 172.0–178.0 million, EBIT EUR 8.0–9.5 million, EBITDA EUR 16.9–18.4 million.
Management anticipates second-half revenues and earnings to match strong prior-year levels, driven by marketing initiatives.
Cash flows and financial position expected to remain solid; equity ratio and dynamic gearing ratio forecasts unchanged.
Latest events from Berentzen-Gruppe
- Profitability surged in H1 2024 despite flat sales, with Grüneberg divestment set to lift margins.BEZ
Q2 20241 Feb 2026 - Record EBIT and margin gains in 2024 set the stage for double-digit growth in 2025.BEZ
Q4 202425 Dec 2025 - Revenue and profit declined year-over-year; outlook lowered amid challenging market conditions.BEZ
Q3 202523 Oct 2025 - Adjusted EBIT and EBITDA surged despite stable revenues and one-off impairment losses.BEZ
Q3 202413 Jun 2025 - Revenue down 4.7% in Q1 2025; outlook for full year remains positive despite market volatility.BEZ
Q1 20255 Jun 2025